Medicare

Organization

A US national health insurance program that approved the use of CGM for intensive insulin-using type 2 diabetes patients in January 2017.

Mentioned in 1 video

Videos Mentioning Medicare

#54–Kevin Sayer, CEO of Dexcom: Continuous glucose monitors–impact of food, sleep, & stress

#54–Kevin Sayer, CEO of Dexcom: Continuous glucose monitors–impact of food, sleep, & stress

Peter Attia MD

A US national health insurance program that approved the use of CGM for intensive insulin-using type 2 diabetes patients in January 2017.